Early-onset colorectal cancer is associated with markedly increased tissue stiffness and fibrosis, suggesting a distinct ...
A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the ...
13hon MSN
A new nanorobot designed to improve immune cell recognition could help treat colorectal cancer
Colorectal cancer, the abnormal growth of cancerous cells in the large intestine or the rectum, is one of the most common ...
To effectively battle cancer, scientists must study the battlefield. Now, in a recent study published in Nature Communications, a multi-institutional research team including The University of Osaka ...
12don MSN
Microbial patterns in colorectal tumors may predict patient survival and disease progression
A recent study shows that bacteria living inside colorectal tumors form distinct ecosystems that are closely linked to how ...
A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the ...
ABT-301, an HDAC1/2/3 inhibitor, enhances immune response and tumor microenvironment, potentially improving immune checkpoint inhibitor efficacy in metastatic colorectal cancer. The phase 1/2 trial ...
Company closed $22M financing to support randomized Phase 2b trial; IND cleared and study initiated; Interim results anticipated in late 2026; topline data expected in H2/2027 ...
A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback